From Lysosomal Storage Diseases to NKT Cell Activation and Back
Lysosomal storage diseases (LSDs) are inherited metabolic disorders characterized by the accumulation of different types of substrates in the lysosome. With a multisystemic involvement, LSDs often present a very broad clinical spectrum. In many LSDs, alterations of the immune system were described....
Main Authors: | Cátia S. Pereira, Helena Ribeiro, M. Fatima Macedo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/18/3/502 |
Similar Items
-
Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients
by: Catia S. Pereira, et al.
Published: (2019-06-01) -
The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-02-01) -
Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial–Lysosomal Axis
by: Myeong Uk Kuk, et al.
Published: (2021-02-01) -
Characterization of Drosophila Saposin-related mutants as a model for lysosomal sphingolipid storage diseases
by: Julia Sellin, et al.
Published: (2017-06-01) -
Lysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle
by: André R. A. Marques, et al.
Published: (2021-03-01)